Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (261-270 of 768) with videos related to

Pageof 77
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2015
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomesC Y Cheah, D Chihara, J E Romaguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantationMary Eapen, Brent R Logan, Mary M Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantationY S Kim, S N Konoplev, F Montemurro, et al.
Bone Marrow Transplantation|April 4, 2000
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulinS Ghosh, R E Champlin, J Englund, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Leukemia Research|March 15, 2008
Altered gene expression in busulfan-resistant human myeloid leukemiaBenigno C Valdez, David Murray, Latha Ramdas, et al.
Blood|September 2, 2006
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationNorbert Schmitz, Mary Eapen, Mary M Horowitz, et al.
Bone Marrow Transplantation|September 6, 2001
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulinsS Ghosh, R E Champlin, N T Ueno, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2014
Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practiceE J Ariza-Heredia, A M Gulbis, K R Stolar, et al.
Leukemia|January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxisRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Pageof 77

Showing results (261-270 of 768) with videos related to

Sort By:
Pageof 77
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2015
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomesC Y Cheah, D Chihara, J E Romaguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantationMary Eapen, Brent R Logan, Mary M Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantationY S Kim, S N Konoplev, F Montemurro, et al.
Bone Marrow Transplantation|April 4, 2000
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulinS Ghosh, R E Champlin, J Englund, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Leukemia Research|March 15, 2008
Altered gene expression in busulfan-resistant human myeloid leukemiaBenigno C Valdez, David Murray, Latha Ramdas, et al.
Blood|September 2, 2006
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationNorbert Schmitz, Mary Eapen, Mary M Horowitz, et al.
Bone Marrow Transplantation|September 6, 2001
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulinsS Ghosh, R E Champlin, N T Ueno, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2014
Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practiceE J Ariza-Heredia, A M Gulbis, K R Stolar, et al.
Leukemia|January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxisRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Pageof 77